Paul Gadiock to Speak at the FDLI Introduction to US Biologics and Biosimilars Training Course
FDA senior attorney Paul Gadiock will speak at the Introduction to US Biologics and Biosimilars Training Course hosted by the Food and Drug Law Institute (FDLI). The event will be held March 20 -21, 2018 in Washington, DC. The introductory course will explore the legal and regulatory obligations of the biologics industry. Mr. Gadiock’s presentation is titled “Regulation of Biological Marketing” and will cover labeling and marketing issues related to biologics. To learn more about the conference or to register click here.